Claus Andersson

Claus Andersson is a General Partner at Sunstone Life Science Ventures, overseeing investments in prescription drugs based on new chemical entities and active pharmaceutical ingredients with well-described mechanisms of action. Claus also serves on the Board of Directors for multiple biotech companies, including Resalis Therapeutics, DiogenX, Rewind Therapeutics, Cardior Pharmaceuticals, and others. Claus has a background in multivariate statistics and chemical engineering from the University of Copenhagen and the Technical University of Denmark.